Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117263) titled 'Study on Carbon lon lrradiation-lnduced PD-1/PD-L1 Expression in Osteosarcoma and Its Synergistic RadiationImmunotherapy Effects' on Jan. 21.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Clinical Technology Research And Development Center of Shanghai Proton and Heavy Ion Center
Condition:
Sarcoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: Experimental group:12;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=306324
Disclaimer: Curated by HT Syndication....